Abstract

Hyperdopaminergic activities are often linked to positive symptoms of schizophrenia, but their neuropathological implications on negative symptoms are rather controversial among reports. Here, we explored the regulatory role of the resting state-neural activity of dopaminergic neurons in the ventral tegmental area (VTA) on social interaction using a developmental rat model for schizophrenia. We prepared the model by administering an ammonitic cytokine, epidermal growth factor (EGF), to rat pups, which later exhibit the deficits of social interaction as monitored with same-gender affiliative sniffing. In vivo single-unit recording and microdialysis revealed that the baseline firing frequency of and dopamine release from VTA dopaminergic neurons were chronically increased in EGF model rats, and their social interaction was concomitantly reduced. Subchronic treatment with risperidone ameliorated both the social interaction deficits and higher frequency of dopaminergic cell firing in this model. Sustained suppression of hyperdopaminergic cell firing in EGF model rats by DREADD chemogenetic intervention restored the event-triggered dopamine release and their social behaviors. These observations suggest that the higher resting-state activity of VTA dopaminergic neurons is responsible for the reduced social interaction of this schizophrenia model.

Details

Title
Resting-state dopaminergic cell firing in the ventral tegmental area negatively regulates affiliative social interactions in a developmental animal model of schizophrenia
Author
Sotoyama Hidekazu 1 ; Namba Hisaaki 2 ; Kobayashi Yutaro 1   VIAFID ORCID Logo  ; Hasegawa Taku 3   VIAFID ORCID Logo  ; Watanabe, Dai 3 ; Nakatsukasa Ena 4 ; Sakimura Kenji 4 ; Furuyashiki Tomoyuki 5   VIAFID ORCID Logo  ; Nawa Hiroyuki 2   VIAFID ORCID Logo 

 Niigata University, Department of Molecular Neurobiology, Brain Research Institute, Niigata, Japan (GRID:grid.260975.f) (ISNI:0000 0001 0671 5144) 
 Niigata University, Department of Molecular Neurobiology, Brain Research Institute, Niigata, Japan (GRID:grid.260975.f) (ISNI:0000 0001 0671 5144); Wakayama Medical University, Department of Physiological Sciences, School of Pharmaceutical Sciences, Wakayama, Japan (GRID:grid.412857.d) (ISNI:0000 0004 1763 1087) 
 Kyoto University, Department of Biological Sciences, Graduate School of Medicine, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033) 
 Niigata University, Department of Animal Model Development, Brain Research Institute, Niigata, Japan (GRID:grid.260975.f) (ISNI:0000 0001 0671 5144) 
 Kobe University, Division of Pharmacology, Graduate School of Medicine, Hyogo, Japan (GRID:grid.31432.37) (ISNI:0000 0001 1092 3077) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
21583188
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2516597448
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.